DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

On November 26, 2025, the United States Patent and Trademark Office (USPTO) issued revised guidelines for determining inventorship of ...

Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based ...

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention.

Zurletrectinib has been included in the “SPARK Program” by China’s National Medical Products Administration (NMPA), a pilot initiative to encourage the development of pediatric anti-tumor drugs.

AI-Powered systems and runway upgrades aim to significantly reduce flight disruptions from fog at Delhi's IGI airport.

The global market is estimated at USD 25,900.5 million in 2025 and is forecast to reach USD 64,187.5 million by 2035, ...

Delhi Airport has enhanced its winter readiness with AI systems, predictive analytics, and an upgraded Airport Predictive ...

Generally speaking, Nvidia’s DLSS technologies have provided better image quality than AMD’s FSR, but they have only been ...

In a pilot study, researchers from North Carolina State University have found a novel kirkovirus that may be associated with colitis – and potentially small colon impactions – in horses. The study ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...